ANNA KUTYS: Open Payments
NPI 1093257552 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$529 in 30 payments from 11 companies in 2025. Trend: 2023 $943 · 2024 $1,395 · 2025 $529
Food & beverage: $529
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $154 |
| GENZYME CORPORATION | 3 | $63 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| Incyte Corporation | 2 | $51 |
| Organon LLC | 3 | $49 |
| Botanix SB Inc | 2 | $45 |
| Janssen Biotech, Inc. | 2 | $38 |
| PFIZER INC. | 1 | $24 |
| Lilly USA, LLC | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: RINVOQ, DUPIXENT, OPZELURA, SKYRIZI, SOFDRA, TREMFYA, Rhapsido, CIBINQO.
Industry payments across PA — which companies pay providers there.
